News

November 15, 2018

Radiation and Hormone Therapy Combo May Help Prevent Cancer’s Return After Prostatectomy

News

Prostate cancer patients who show signs of disease progression after surgery to remove the prostate may benefit by combining standard therapy with short-term androgen deprivation (STAD) and pelvic lymph node ... Read more

November 14, 2018

Phase 3 Trial of Relugolix for Advanced Prostate Cancer Completes Patient Enrollment

News

A Phase 3 trial evaluating Myovant Sciences’ relugolix as a treatment for advanced prostate cancer patients who are sensitive to androgen deprivation treatments has completed patient enrollment, the company announced. The ... Read more

November 8, 2018

Phase 2 Trial of Irofulven to Treat Metastatic Castration-Resistant Prostate Cancer Opens in Denmark

News

Oncology Venture announced that patient enrollment has begun in a Phase 2 study evaluating irofulven as a possible treatment for metastatic castration-resistant prostate cancer (mCRPC). Specifically, the trial (NCT03643107) is for patients ... Read more

November 7, 2018

Prostate Cancer Foundation Grants $5.5M in Research Funding to Challenge Award Winners

News

More than $5.5 million in funding from the Prostate Cancer Foundation (PCF) will enable six teams of scientists to pursue innovative therapeutic strategies for advanced prostate cancer. Announced at the end ... Read more

November 1, 2018

Certain Prostate Cancer Patients May Benefit From Higher Radiation Doses in Fewer Sessions, Study Shows

News

Stereotactic body radiation therapy (SBRT) — a kind of radiation therapy that delivers high doses of radiation over a shorter treatment course — is as safe and effective as ... Read more

October 31, 2018October 31, 2018

Baseline PSA Screening During Midlife Predicts Prostate Cancer in Black Men, Study Finds

News

Measuring PSA levels during midlife — between 40 and 64 years — could help predict the likelihood an African-American man has of developing prostate cancer up to 12 years ... Read more

October 26, 2018

Stereotactic Radiation Shows Ability to Significantly Extend Survival in Cancer Patients with Multiple Metastasis

News

Patients whose cancer returns at multiple sites after treatment — called oligometastatic cancer — are generally thought incurable, but a recent Phase 2 trial found that a highly precise ... Read more

October 24, 2018

Rubraca Shrank Tumors in Nearly Half of Advanced Prostate Cancer Patients with BRCA Mutations

News

Rubraca (rucaparib), Clovis Oncology‘s PARP inhibitor, shrank tumors in 44% of metastatic castration-resistant prostate cancer (mCRPC) patients with BRCA mutations included in a Phase 2 clinical trial, the company ... Read more

October 22, 2018

Baylor Research Team Gets $6.3M to Study Disparities Among Minorities with Prostate, Breast Cancers

News

The National Cancer Institute (NCI) has awarded a Baylor College of Medicine research team $6.3 million to develop patient-derived mouse models aimed at understanding the biological reasons behind racial ... Read more

October 18, 2018October 18, 2018

Prostate and Small Cell Cancers of the Lung Share Genetic Drivers, Study Finds

News

Small cell cancers — cancers with very poor prognosis that often develop from less-aggressive tumors as a means to evade treatment — may be driven by common mechanisms regardless ... Read more